Statistics
Publications
12
Citations
1.8K
H-Index
12
Active since
2014
Robin J. Gunn is an author at Mirati Therapeutics (United States) specializing in drug discovery, molecular oncology, and pharmacology.
Publications per year
2014–2024
12
12
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
Jill Hallin, Vickie Bowcut, Andrew Calinisan et al. · Nature Medicine · 2022 · 507 citations
HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia
Nabanita Das, Varun Dewan, Peter M. Grace et al. · Cell Reports · 2016 · 158 citations · Full text
Christopher R. Smith, Ruth Aranda, Thomas P. Bobinski et al. · Journal of Medicinal Chemistry · 2022 · 151 citations · Full text
Pharmacy, Oncology, Pharmacology +15
John M. Ketcham, Jacob R. Haling, Shilpi Khare et al. · Journal of Medicinal Chemistry · 2022 · 94 citations · Full text
1–5 of 12